The efficacy of anti‐VEGF drugs toward triple‐negative breast cancer patients is limited, and the hypoxia induced by this VEGF inhibitor can promote tumor invasion and metastasis in mice, which is believed to be caused by angiogenesis,96 and this new vessel was proved to be VM.73 This evidence concerns the gene VEGFA and neoplasm.